HK Stock MarketDetailed Quotes

01889 SANAI HEALTH GP

Watchlist
  • 0.040
  • 0.0000.00%
Market Closed Mar 28 16:08 CST
128.41MMarket Cap6.67P/E (TTM)

About SANAI HEALTH GP Company

The group is a vertically integrated specialty pharmaceutical group that specializes in manufacturing, marketing and selling branded prescription, over-the-counter Western and proprietary Chinese medicine products, including proprietary Chinese medicine injections, for the Chinese market. The group's product range is diversified, including 28 types of drugs currently produced and marketed for the therapeutic market in China where medical demand is huge, that is, drugs used to relieve symptoms such as respiratory, cardiovascular, gastroenterology, infectious diseases and cancer. The group's main products include 14 different Western medicines and 14 proprietary Chinese medicine products. Of these, 22 require a doctor's prescription, while the remaining 6 are over-the-counter medicines that can be used even without a doctor's prescription. These main products are part of the Group's diversified product portfolio. A total of 125 products in the product portfolio have been approved and registered by the China Food and Drug Administration, and the Group also has the required production technology and production capacity. Once the market demand for individual products is ripe and reasonable profits can be expected, they can be produced and sold at any time. Based on internal market research, the group selects products that are expected to have strong market demand and high profit potential for production and marketing. Currently, the 28 major products selected for production and sale are all products that the Group believes have higher profit potential than other products in the portfolio. The Group's core strengths include the Group's “Three Love” brand (which is widely recognized for its high quality and good reputation) and the Group's production and marketing platform (which produces and markets 14 different kinds of prescription Western medicines and a diversified combination of 14 proprietary Chinese medicines). The Group plans to use these advantages to increase the market share of its current marketing products and launch new products in key target markets.

Company Profile

Symbol01889
Company NameSANAI HEALTH GP
ISINKYG7785S1075
Listing Date02/01/2007
Issue Price1.80
Shares Offered445.15M share
Founded03/21/2006
RegistrationCayman Islands
SecretaryWanshan Li
Audit InstitutionChina Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeGrand Pavilion,Hibiscus Way, 802 West Bay Road, P.O. Box 31119, KY1-1205, Cayman Islands
Head Office and Principal Place of BusinessUnit 5, 7th floor, Nanyang Plaza, 57 Hung To Road, Kwun Tong, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees71
MarketHong Kong motherboard
Phone(852) 2827 6100
Fax(852) 2827 6099
Emailwuyi.ir@wuyi-pharma.com.hk
Business Sanai Health Industry Group Co., Ltd. is an investment holding company mainly engaged in general trading business and medical products business. The company operates through three business segments. The Pharmaceutical Products Division is mainly engaged in developing, manufacturing, marketing and selling pharmaceutical products, selling medical-related software and providing consulting services. The Financial Leasing Division is mainly engaged in providing financial leasing services. Other general trade segments mainly sell general trade products such as fitness equipment and electrical appliances.

Company Executives

  • Name
  • Position
  • Salary
  • Chengqing Chen
  • Executive Director
  • 206.00K
  • Rongqing Zhang
  • Executive Director,Nomination Committee Member,Remuneration Committee Member
  • 438.00K
  • Borui Gao
  • Executive Director
  • 485.00K
  • Zhaoyang Yuan
  • Executive Director
  • 1.88M
  • Hao She
  • legal representative,Executive Director
  • 1.44M
  • Yuan Xiu
  • Non-Executive Director
  • 765.00K
  • Yizhun Zhu
  • Independent Non-Executive Director,Nomination Committee Member,Audit Committee Member,Remuneration Committee Member
  • 103.00K
  • Qilin Xu
  • Audit Committee Chairman,Independent Non-Executive Director,Remuneration Committee Chairman,Nomination Committee Member
  • 155.00K
  • Ruigen Zhang
  • Nomination Committee Chairman,Independent Non-Executive Director,Remuneration Committee Member,Audit Committee Member
  • 103.00K
  • Wanshan Li
  • Authorized Representative,Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg